Grading of Urothelial Carcinoma and The New "World Health Organisation Classification of Tumours of the Urinary System and Male Genital Organs 2016".
暂无分享,去创建一个
M. Babjuk | R. Sylvester | E. Compérat | S. Shariat | R. Zigeuner | M. Rouprêt | B. V. van Rhijn | P. Gontero* | M. Burger | E. Compérat | A. H. Mostafid | J. Palou | P. Gontero
[1] N. Schultz,et al. NEXT GENERATION SEQUENCING OF NON‐MUSCLE INVASIVE BLADDER CANCER REVEALS POTENTIAL BIOMARKERS AND RATIONAL THERAPEUTIC TARGETS: PD48‐11 , 2017, European urology.
[2] J. McKenney,et al. Large nested variant of urothelial carcinoma: a clinicopathological study of 36 cases , 2017, Histopathology.
[3] M. Babjuk,et al. Prognostic Performance and Reproducibility of the 1973 and 2004/2016 World Health Organization Grading Classification Systems in Non-muscle-invasive Bladder Cancer: A European Association of Urology Non-muscle Invasive Bladder Cancer Guidelines Panel Systematic Review. , 2017, European urology.
[4] T. Ørntoft,et al. Prognostic Impact of a 12-gene Progression Score in Non-muscle-invasive Bladder Cancer: A Prospective Multicentre Validation Study. , 2017, European urology.
[5] A. Hartmann,et al. Increased Proliferation as Independent Predictor of Disease Recurrence in Initial Stage pTa Urothelial Bladder Cancer , 2017, Bladder cancer.
[6] M. Höglund,et al. Molecular classification of urothelial carcinoma: global mRNA classification versus tumour‐cell phenotype classification , 2017, The Journal of pathology.
[7] Maximilian Burger,et al. EAU Guidelines on Non-Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016. , 2017, European urology.
[8] T. Kwast,et al. Analysis of papillary urothelial carcinomas of the bladder with grade heterogeneity: supportive evidence for an early role of CDKN2A deletions in the FGFR3 pathway , 2017, Histopathology.
[9] G. Guazzoni,et al. Active surveillance for low‐risk non‐muscle‐invasive bladder cancer: mid‐term results from the Bladder cancer Italian Active Surveillance (BIAS) project , 2016, BJU international.
[10] Alfred Rademaker,et al. Genomic characterization of high-risk non-muscle invasive bladder cancer , 2016, Oncotarget.
[11] Wun-Jae Kim,et al. How do we manage high-grade T1 bladder cancer? Conservative or aggressive therapy? , 2016, Investigative and clinical urology.
[12] Jonathan I. Epstein,et al. WHO Classification of of Tumours of the Urinary System and Male Genital Organs , 2016 .
[13] J. Epstein,et al. Significance of a minor high-grade component in a low-grade noninvasive papillary urothelial carcinoma of bladder. , 2016, Human pathology.
[14] M. Fernö,et al. A Molecular Pathologic Framework for Risk Stratification of Stage T1 Urothelial Carcinoma. , 2015, European urology.
[15] L. Bégin,et al. Inverted urothelial carcinoma: a series of 12 cases with a wide morphologic spectrum overlapping with the large nested variant. , 2015, Human pathology.
[16] Soum D. Lokeshwar,et al. Impact of 2004 ISUP/WHO classification on bladder cancer grading , 2015, World Journal of Urology.
[17] O. Cussenot,et al. Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old , 2015, Virchows Archiv.
[18] G. Hidas,et al. Mixed high and low grade bladder tumors--are they clinically high or low grade? , 2014, The Journal of urology.
[19] S. Jun,et al. Expression of miRNAs and ZEB1 and ZEB2 correlates with histopathological grade in papillary urothelial tumors of the urinary bladder , 2014, Virchows Archiv.
[20] A. Venyo. Microcystic Variant of Urothelial Carcinoma , 2013, Advances in urology.
[21] G. Kristiansen,et al. An interobserver reproducibility study on invasiveness of bladder cancer using virtual microscopy and heatmaps , 2013, Histopathology.
[22] M. Fernö,et al. Toward a molecular pathologic classification of urothelial carcinoma. , 2013, The American journal of pathology.
[23] Z. Kos,et al. Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance , 2013, Virchows Archiv.
[24] Ju-Han Lee,et al. CD74 expression is increased in high‐grade, invasive urothelial carcinoma of the bladder , 2013, International journal of urology : official journal of the Japanese Urological Association.
[25] F. Montorsi,et al. Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors. , 2011, The Journal of urology.
[26] J. Epstein,et al. Large Nested Variant of Urothelial Carcinoma: 23 Cases Mimicking von Brunn Nests and Inverted Growth Pattern of Noninvasive Papillary Urothelial Carcinoma , 2011, The American journal of surgical pathology.
[27] A. Hartmann,et al. The WHO classification of 1973 is more suitable than the WHO classification of 2004 for predicting survival in pT1 urothelial bladder cancer , 2011, BJU international.
[28] T. H. van der Kwast,et al. Molecular grade (FGFR3/MIB-1) and EORTC risk scores are predictive in primary non-muscle-invasive bladder cancer. , 2010, European urology.
[29] Samay Jain,et al. Comparison of 2004 and 1973 World Health Organization grading systems and their relationship to pathologic staging for predicting long-term prognosis in patients with urothelial carcinoma. , 2010, Urology.
[30] A. Zlotta,et al. The pathologist's mean grade is constant and individualizes the prognostic value of bladder cancer grading. , 2010, European urology.
[31] Chin-Chen Pan,et al. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. , 2010, American journal of clinical pathology.
[32] G. Kristiansen,et al. Prognostic accuracy of individual uropathologists in noninvasive urinary bladder carcinoma: a multicentre study comparing the 1973 and 2004 World Health Organisation classifications. , 2010, European urology.
[33] T. H. van der Kwast,et al. Prediction of progression of non-muscle-invasive bladder cancer by WHO 1973 and 2004 grading and by FGFR3 mutation status: a prospective study. , 2008, European urology.
[34] R. Montironi,et al. Immunohistochemical Evaluation of Global DNA Methylation and Histone Acetylation in Papillary Urothelial Neoplasm of Low Malignant Potential , 2008, International journal of immunopathology and pharmacology.
[35] T. H. van der Kwast,et al. FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours. , 2007, European urology.
[36] C. Acar,et al. Comparison of 1998 WHO/ISUP and 1973 WHO Classifications for Interobserver Variability in Grading of Papillary Urothelial Neoplasms of the Bladder , 2007, Urologia Internationalis.
[37] V. Paradis,et al. Aurora-A/STK-15 is a predictive factor for recurrent behaviour in non-invasive bladder carcinoma: a study of 128 cases of non-invasive neoplasms , 2007, Virchows Archiv.
[38] I. Sesterhenn,et al. World health organization classifications of tumours. pathology and genetics of tumours of the urinary system and male genital organs , 2005 .
[39] D. Nicol,et al. Papillary urothelial neoplasm of low malignant potential: reliability of diagnosis and outcome , 2004, BJU international.
[40] A. Leong,et al. Histologic grading of noninvasive papillary urothelial tumors: validation of the 1998 WHO/ISUP system by immunophenotyping and follow-up. , 2004, American journal of clinical pathology.
[41] A. Marx,et al. World Health Organization Classification of Tumors. Pathology and Genetics of Tumors of the Urinary System and Male Genital Organs , 2004 .
[42] V. Reuter,et al. Nested Variant of Urothelial Carcinoma: A Clinicopathologic and Immunohistochemical Study of 12 Cases , 2003, Modern Pathology.
[43] J. Baak,et al. Reproducibility and prognostic variability of grade and lamina propria invasion in stages Ta, T1 urothelial carcinoma of the bladder. , 2003, The Journal of urology.
[44] W. Murphy,et al. Interobserver discrepancy using the 1998 World Health Organization/International Society of Urologic Pathology classification of urothelial neoplasms: practical choices for patient care. , 2002, The Journal of urology.
[45] H. Samaratunga,et al. Comparison of WHO/ISUP and WHO classification of noninvasive papillary urothelial neoplasms for risk of progression. , 2002, Urology.
[46] S. Johansson,et al. Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression. , 2002, The Journal of urology.
[47] A. Formiconi,et al. Biologic Differences Between Noninvasive Papillary Urothelial Neoplasms of Low Malignant Potential and Low-Grade (Grade 1) Papillary Carcinomas of the Bladder , 2001, The American journal of surgical pathology.
[48] J. McKenney,et al. Morphologic Expressions of Urothelial Carcinoma In Situ: A Detailed Evaluation of Its Histologic Patterns With Emphasis on Carcinoma In Situ With Microinvasion , 2001, The American journal of surgical pathology.
[49] M. Droller. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma. , 2001, The Journal of urology.
[50] D. Bostwick,et al. Cancer heterogeneity and its biologic implications in the grading of urothelial carcinoma , 2000, Cancer.
[51] J. Cheville,et al. Flat intraepithelial lesions of the urinary bladder , 2000, Cancer.
[52] Lawrence D. True,et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder , 1998 .
[53] F. Mostofi,et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee. , 1998, The American journal of surgical pathology.
[54] F. Debruyne,et al. Grading in superficial bladder cancer. (1). Morphological criteria. , 1988, British journal of urology.
[55] B. Norlén,et al. Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up. , 2010, Scandinavian journal of urology and nephrology.
[56] S. Loening,et al. Superficial bladder cancer: progression and recurrence. , 1983, The Journal of urology.
[57] J. B. Stern. Unusual benign bladder tumor of Brunn nest origin. , 1979, Urology.